These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17308733)

  • 21. National expenditure on health research in South Africa: what is the benchmark?
    Paruk F; Blackburn JM; Friedman IB; Mayosi BM
    S Afr Med J; 2014 May; 104(7):468-74. PubMed ID: 25214045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How much are we spending? The estimation of research expenditures on cardiovascular disease in Canada.
    de Oliveira C; Nguyen VH; Wijeysundera HC; Wong WW; Woo G; Liu PP; Krahn MD
    BMC Health Serv Res; 2012 Aug; 12():281. PubMed ID: 22929001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A source of innovation.
    Gillespie DG
    Integration; 1992 Dec; (34):2-7. PubMed ID: 12317827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
    Røttingen JA; Regmi S; Eide M; Young AJ; Viergever RF; Ardal C; Guzman J; Edwards D; Matlin SA; Terry RF
    Lancet; 2013 Oct; 382(9900):1286-307. PubMed ID: 23697824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public and private donor financing for health in developing countries.
    Howard LM
    Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Financial management of large, multi-center trials in a challenging funding milieu.
    Lovegreen O; Riggs D; Staten MA; Sheehan P; Pittas AG
    Trials; 2018 May; 19(1):267. PubMed ID: 29724229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NIH budget and the future of biomedical research.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(16):1665-7. PubMed ID: 16625006
    [No Abstract]   [Full Text] [Related]  

  • 28. Crowdfunding for cancer research: the TRACe campaign as an example.
    Gallerani G; Fici P; Coatti A; Mariotti P; Passeri F; Battistelli L
    Lancet Oncol; 2019 May; 20(5):622-624. PubMed ID: 31044702
    [No Abstract]   [Full Text] [Related]  

  • 29. [Availability of generic drugs in the public sector and prices in the private sector in different regions of Brazil].
    Miranda ES; Pinto Cdu B; dos Reis AL; Emmerick IC; Campos MR; Luiza VL; Osorio-de-Castro CG
    Cad Saude Publica; 2009 Oct; 25(10):2147-58. PubMed ID: 19851615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uganda's increasing dependence on development partner's support for immunization - a five year resource tracking study (2012 - 2016).
    Kamya C; Abewe C; Waiswa P; Asiimwe G; Namugaya F; Opio C; Ampeire I; Lagony S; Muheki C
    BMC Public Health; 2021 Jan; 21(1):160. PubMed ID: 33468094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the medical expenditure of the basic health insurance in Morocco.
    Yassine A; Hangouche AJ; El Malhouf N; Maarouf S; Taoufik J
    Pan Afr Med J; 2020; 35():115. PubMed ID: 32637013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Economic crisis and disparities in spending, supply, and use of public and private health services in Brazil from 2011 to 2019].
    Costa DCAR; Moreira JPL; Cardoso AM; Mattos LV; Andrietta LS; Bahia L
    Cad Saude Publica; 2022; 38(10):e00262221. PubMed ID: 36449852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary care careers among recent graduates of research-intensive private and public medical schools.
    Choi PA; Xu S; Ayanian JZ
    J Gen Intern Med; 2013 Jun; 28(6):787-92. PubMed ID: 23225257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Private sector joins family planning effort.
    Front Lines; 1989 Dec; ():6, 13. PubMed ID: 12343476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical investigations for SUS, the Brazilian public health system.
    Paula AP; Giozza SP; Pereira MZ; Boaventura PS; Santos LM; Sachetti CG; Tamayo CO; Kowalski CC; Elias FT; Serruya SJ; Guimarães R
    Sao Paulo Med J; 2012; 130(3):179-86. PubMed ID: 22790551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 37. Expanding Coverage of Oncology Drugs in an Aging, Upper-Middle-Income Country: Analyses of Public and Private Expenditures in Chile.
    Vargas V; Leopold C; Castillo-Riquelme M; Darrow JJ
    J Glob Oncol; 2019 Dec; 5():1-17. PubMed ID: 31860377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracking financial flows for immunization in Honduras.
    Valdés W; Janusz CB; Molina Aguilera IB; Mendoza L; Díaz IY; Resch S
    Vaccine; 2015 May; 33 Suppl 1():A85-92. PubMed ID: 25919182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public health. Public-private partnerships and scientific imperialism.
    Tucker TJ; Makgoba MW
    Science; 2008 May; 320(5879):1016-7. PubMed ID: 18497279
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular research funding in Europe: The Netherlands. Interview by Jennifer Taylor.
    Doevendans P
    Circulation; 2008 Feb; 117(6):f31-3. PubMed ID: 18268157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.